You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 9,572,803

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,572,803

Title:	Abuse resistant drug formulation
Abstract:	A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
Inventor(s):	Habib; Walid A. (Maple Grove, MN), Hamed; Ehab (Maple Grove, MN), Vega Zepeda; Manuel A. (Minneapolis, MN)
Assignee:	Cima Labs Inc. (Brooklyn Park, MN)
Application Number:	13/728,801
Patent Claims:	1. A coated granulate, comprising: a granulate consisting of at least one opioid in an amount between about 0.1 to about 90 percent by weight of the granulate mixed with two materials, wherein said first material is ethyl cellulose and is present in an amount between 5 and 75 percent by weight of the granulate and a second material that is selected from the group consisting of hydroxypropylmethylcellulose, methylcellulose, hydroxyethylmethylcellulose, and hydroxyethylcellulose and is present in an amount between 15 and 50 percent by weight of the granulate; and a coating on said granulate provided in an amount of between about 20 and about 7 5 percent by weight of the coated granulate exhibiting crush resistance, wherein the coating comprises ethylcellulose. 2. The coated granulate of claim 1 wherein the second material is hydroxypropylmethylcellulose. 3. The coated granulate of claim 1 wherein the at least one opioid is selected from the group consisting of oxycodone, codeine, hydrocodone, morphine, hydromorphone, oxymorphone, methadone, propoxyphene, meperidine, fentanyl, buprenorphine, butorphanol, dezocine, levomethadyl acetate, levorphanol, nalbuphine, pentazocine, remifentanil, sufentanil, and tramadol. 4. The coated granulate of claim 2 wherein the at least one opioid is selected from the group consisting of oxycodone, codeine, hydrocodone, morphine, hydromorphone, oxymorphone, methadone, propoxyphene, meperidine, fentanyl, buprenorphine, butorphanol, dezocine, levomethadyl acetate, levorphanol, nalbuphine, pentazocine, remifentanil, sufentanil, and tramadol.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.